Methemoglobinemia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:
==Overview==
==Overview==


==Methemoglobinemia must be differentiated from other diseases that cause [[hypoxia]] and [[cyanosis]], such as [[heart failure]], [[pulmonary embolism]], [[polycythemia]], [[anemia]], etc.==
Methemoglobinemia must be differentiated from other diseases that cause [[hypoxia]] and [[cyanosis]], such as [[heart failure]], [[pulmonary embolism]], [[polycythemia]], [[anemia]], etc.


==Differentiating Methemoglobinemia from other Diseases==
==Differentiating Methemoglobinemia from other Diseases==

Revision as of 13:22, 15 August 2018

Methemoglobinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Methemoglobinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Methemoglobinemia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Methemoglobinemia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Methemoglobinemia differential diagnosis

on Methemoglobinemia differential diagnosis

Methemoglobinemia differential diagnosis in the news

Blogs on Methemoglobinemia differential diagnosis

Directions to Hospitals Treating Methemoglobinemia

Risk calculators and risk factors for Methemoglobinemia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aksiniya Stevasarova, M.D.

Overview

Methemoglobinemia must be differentiated from other diseases that cause hypoxia and cyanosis, such as heart failure, pulmonary embolism, polycythemia, anemia, etc.

Differentiating Methemoglobinemia from other Diseases

  • There are several conditions that can present similar to methemoglobinemia. Note that the hypoxia in methemogobinemia will be unresponsive to oxygen treatment, in comparison to cardiac and pulmonary cause. Worth mentioning is that high doses of antidotal treatment for methemogobinemia (Methylene blue) can also cause cyanotic discoloration of the skin, but this does not mean the the treatment is not working.
  • Methemoglobinemia can present with similar signs and symptoms of other conditions causing hypoxia (as listed below). Note that the hypoxia in methemogobinemia will be unresponsive to oxygen treatment, in comparison to cardiac and pulmonary causes of hypoxia.

Heart failure

Pulmonary embolism

Polycythemia[1]Anemia

Rasbirucase (Rx Tumor Lysis Syndrome) [2]

Metabolic Acidosis

Methylene Blue treatment

Sulfhemoglobin

Asthma

  • Depending on the levels of MetHb in the blood we can observe different clinical presentation as follows[3] [4]
  • MetHb levels of 15% lead to skin and blood color (chocolate-brown) changes .
  • MetHb levels above 15% lead to hypoxia.
  • MetHb levels above 70% lead to death.

References

  1. Soliman DS, Yassin M (2018). "Congenital methemoglobinemia misdiagnosed as polycythemia vera: Case report and review of literature". Hematol Rep. 10 (1): 7221. doi:10.4081/hr.2018.7221. PMC 5907642. PMID 29721250.
  2. Khan M, Paul S, Farooq S, Oo TH, Ramshesh P, Jain N (2017). "Rasburicase-Induced Methemoglobinemia in a Patient with Glucose-6- Phosphate Dehydrogenase Deficiency". Curr Drug Saf. 12 (1): 13–18. doi:10.2174/1574886312666170111151246. PMID 28078984.
  3. 3.0 3.1 do Nascimento TS, Pereira RO, de Mello HL, Costa J (2008). "Methemoglobinemia: from diagnosis to treatment". Rev Bras Anestesiol. 58 (6): 651–64. PMID 19082413.
  4. Bradberry SM (2003). "Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue". Toxicol Rev. 22 (1): 13–27. PMID 14579544.

Template:WS Template:WH